Product NDC: | 17478-040 |
Proprietary Name: | Lorazepam |
Non Proprietary Name: | Lorazepam |
Active Ingredient(s): | 2 mg/mL & nbsp; Lorazepam |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 17478-040 |
Labeler Name: | Akorn, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075025 |
Marketing Category: | ANDA |
Start Marketing Date: | 19800701 |
Package NDC: | 17478-040-01 |
Package Description: | 10 VIAL in 1 CARTON (17478-040-01) > 1 mL in 1 VIAL |
NDC Code | 17478-040-01 |
Proprietary Name | Lorazepam |
Package Description | 10 VIAL in 1 CARTON (17478-040-01) > 1 mL in 1 VIAL |
Product NDC | 17478-040 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Lorazepam |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 19800701 |
Marketing Category Name | ANDA |
Labeler Name | Akorn, Inc. |
Substance Name | LORAZEPAM |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |